The selective serotonin reuptake inhibitor paroxetine is effective in more generalized and in less generalized social anxiety disorder
The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
Rationale The DSM-IV includes the specifier "generalized" to refer to social anxiety disorder (social phobia) patients if the fears include "most social situations". The focus on interventions such as the selective serotonin reuptake inhibitors (SSRIs) for generalized social anxiety disorder arguably runs the risk that inadequate treatment will be provided to patients with the non-generalized or discrete subtypes. There are, however, few data to address whether more generalized and less generalized subgroups of social anxiety disorder differ in response to medication.Objective To compare response of more generalized and less generalized social anxiety disorder to pharmacotherapy.Methods Data from three randomized placebo-controlled double-blind multicenter trials of the SSRI paroxetine in social anxiety disorder were pooled. Response on the Clinical Global Impression Global Improvement item was analyzed using logistic regression, and change in total Liebowitz Social Anxiety Score was analyzed using analysis of variance, with both models incorporating treatment (paroxetine vs placebo), subgroup (more generalized vs less generalized), demographic, and clinical variables.Results The prevalence of more generalized social anxiety disorder was higher in females than in males. However, there was no significant difference in terms of age or clinical characteristics (duration of condition, baseline pulse, mean arterial blood pressure). At treatment endpoint there were significant treatment effects (for paroxetine vs placebo), but no significant subgroup effects (for more generalized vs less generalized).Conclusions Although the current database is limited insofar as few patients with discrete social anxiety disorder would have been included, it is helpful in addressing the value of medication for patients lying on the spectrum from generalized to non-generalized and discrete social anxiety disorder. Paroxetine was effective in both more generalized and in less generalized social anxiety disorder.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“SSRIs, on the other hand, may be useful for patients with both more limited or more generalized social anxiety disorder 99 .”
From The clinical characterization of the adult patient with an anxiety or related disorder aimed at personalization of management (2021) · cites this paper as [99]
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
Kessler, R. C. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950010008002 · Cited by 12,370
(1976) · Medical Entomology and Zoology · Cited by 8,899
Schneier (1992) · doi:10.1001/archpsyc.1992.01820040034004 · Cited by 1,142 · cited 1×
“National and cross-national studies of social anxiety disorder (or social phobia) have documented that this disorder is highly prevalent in many countries (with prevalences ranging, for example, from 2.6 to 13.3% in the United States), that it has a chronic course when untreated, and that it is associated with signifi…”
BackgroundInfluentialPsychometric properties of the Liebowitz Social Anxiety Scale
HEIMBERG, R. G., HORNER, K. J., JUSTER, H. R., SAFREN, S. A., BROWN, E. J., SCHNEIER, F. R., & LIEBOWITZ, M. R. (1999) · Psychological Medicine · doi:10.1017/s0033291798007879 · Cited by 968 · cited 2×
“As part of the post hoc analysis of the data, two definitions of more generalized and less generalized social anxiety disorder were devised using the baseline LSAS, a 24-item scale in which fear/anxiety and avoidance associated with different social situations are each rated on a 4-point scale (absent, mild, moderate,…”
MethodMcDougle, C. J. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950040046006 · Cited by 570
Functional impairment in social phobia.
Schneier, F. R., Heckelman, L., Garfinkel, R. S., Campeas, R. B., Fallon, B. A., Gitow, A., Street, L. L., Bene, D. D., & Liebowitz, M. R. (1994) · PubMed · Cited by 534
Phenelzine vs Atenolol in Social Phobia: A Placebo-Controlled Comparison
Liebowitz, M. R., Schneier, F., Campeas, R., Hollander, E., Hatterer, J., Fyer, A., Gorman, J., Papp, L., Davies, S., Gully, R., et al. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.49.4.290 · Cited by 444
Social Phobia Subtypes in the National Comorbidity Survey
Kessler, R. C., Stein, M. B., & Berglund, P. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.5.613 · Cited by 398
Self-citationSocial phobia: A comparison of specific and generalized subtypes and avoidant personality disorder.
Turner, S. M., Beidel, D. C., & Townsley, R. M. (1992) · Journal of Abnormal Psychology · doi:10.1037//0021-843x.101.2.326 · Cited by 282 · cited 1×
“Further understanding of the heterogeneity of social anxiety disorder (Holt et al. 1992; Turner et al. 1992 ) may be useful for predicting response to pharmacotherapy.”
Background
Cited by
Blomstrom-Lundqvist (2003) · doi:10.1161/01.cir.0000091380.04100.84 · Cited by 955
Blomström-Lundqvist, C., Scheinman, M. M., Aliot, E. M., Alpert, J. S., Calkins, H., Camm, A. J., Campbell, W. B., Haines, D. E., Kuck, K. H., Lerman, B. B., et al. (2003) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.08.013 · Cited by 689
BlomstromLundqvist, C. (2003) · European Heart Journal · doi:10.1016/j.ehj.2003.08.002 · Cited by 263
Social Anxiety Disorder: (532272011-001)
(2008) · PsycEXTRA Dataset · doi:10.1037/e532272011-001 · Cited by 258
Self-citationPigott, T. A. (2003) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(03)00040-6 · Cited by 205
Metadata
- Authors
- Stein, D., Stein, M., Goodwin, W., Kumar, R., & Hunter, B.
- Affiliations
- Stellenbosch University (ZA)
- University of California San Diego (US)
- GlaxoSmithKline (United Kingdom) (GB)
- Venue
- Psychopharmacology
- Published
- 2001-11-01
- Volume
- 158
- Issue
- 3
- Pages
- 267-272
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- OpenAlex
- W2065666574
- Cited by
- 39
- References
- 31
- Citations by year
- 2022: 1 · 2021: 1 · 2018: 1 · 2016: 2 · 2013: 1
- FWCI
- 9.46
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Maternal Mental Health During Pregnancy and Postpartum
- Keywords
- paroxetine, social anxiety disorder, generalized social anxiety, selective serotonin reuptake inhibitors, pharmacotherapy response, Liebowitz Social Anxiety Scale, Clinical Global Impression Scale
- MeSH terms
- Adult, Analysis of Variance, Anxiety Disorders, Double-Blind Method, Female, Humans, Male, Middle Aged, Confidence Intervals, Logistic Models, Odds Ratio, Selective Serotonin Reuptake Inhibitors, Paroxetine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The selective serotonin reuptake inhibitor paroxetine is effective in more generalized and in less generalized social anxiety disorder. https://app.cochat.ai/papers/10.1007/s002130100880
- The paper
- Stein, D., Stein, M., Goodwin, W., Kumar, R., & Hunter, B. (2001). The selective serotonin reuptake inhibitor paroxetine is effective in more generalized and in less generalized social anxiety disorder. Psychopharmacology. https://doi.org/10.1007/s002130100880
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.